SkyCell is a leading airfreight container provider with the mission to supply the safest pharma containers worldwide.

SkyCell is the designer of “smart containers” powered by software to maintain constant conditions for drugs that need to be kept at strict temperatures, humidity levels, and levels of vibration, which are in turn used to transport pharmaceuticals around the globe on behalf of drug companies.

SkyCell was founded in 2013 by Richard Ettl and Nico Ros. The company is headquartered in Zurich, Zurich, Switzerland.

SkyCell uses a unique combination of hardware, software and service to enable us to master logistical challenges and eliminate temperature excursion.

SkyCell’s approach brings this right down, reducing complexity through a highly innovative smart container that allows pharma companies to optimise supply chains using data to predict and control risk.


SkyCell is one the big four providers of pharma containers in the industry and is growing fast. The company has been audited by more than 12 of the biggest 20 pharmaceutical companies and passed all tests with tailwind.


SkyCell is backed by Swiss Entrepreneurs Fund, MVM Partners LLP, UBS, BCGE Bank and others. The company raised $62M in an overscribed round on Apr 28, 2020. This brings SkyCell's total funding to $98M to date.



  • Year founded: 2013
  • Funding Info: $98M over 3 Rounds (Latest Funding Type: Venture- Series Unknown)
  • Yearly Revenue: NA
  • Employee Size: 51-200
  • Business Valuation: NA
  • City/Town: Zürich
  • State: Zürich
  • Country: Switzerland
Related businesses